Internal Medicine, Infectious Disease · Houston, TX
NPI
1336350321
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1790 Dryden Road, Ms:bcm620, Ste 06.12
Houston, TX, 77030
Phone (713) 798-4211
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
334 services
Medicare patients, 2024
189
Average age 69
Drug cost, 2024
$1.3M
1,535 prescriptions
Company payments, 2024
$291
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laila E Woc-Colburn was code 99233 (hospital e&m - subsequent), 121 times for 48 patients. In total Laila E Woc-Colburn billed 334 services in 12 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 121 | 48 | $92.85 | $11K |
| 99215 Office E&M - Established | Office | 113 | 88 | $135.12 | $15K |
| 99223 Hospital E&M - Initial | Facility | 37 | 37 | $127.94 | $4,734 |
| 99214 Office E&M - Established | Office | 17 | 16 | $82.71 | $1,406 |
| 99212 Office E&M - Established | Office | 16 | 16 | $43.14 | $690 |
| 99205 Office E&M - New | Office | 13 | 13 | $151.70 | $1,972 |
By year: 2022 $25K for 276 services; 2023 $28K for 305 services; 2024 $36K for 334 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laila E Woc-Colburn prescribed most often to Medicare patients was Doxycycline Hyclate, with 171 prescriptions and refills. In total Laila E Woc-Colburn wrote 1,535 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 171 | 289 | 53 | $6,306 |
| Ceftriaxone Ceftriaxone Sodium | 158 | 158 | 38 | $26K |
| Daptomycin Generic | 95 | 95 | 24 | $135K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 92 | 92 | 11 | $361K |
| Cephalexin Generic | 64 | 109 | 15 | $1,929 |
| Ertapenem Ertapenem Sodium | 62 | 62 | 22 | $39K |
| Vancomycin Hcl Generic | 56 | 56 | 17 | $9,220 |
| Levofloxacin Generic | 52 | 78 | 22 | $745 |
| Amoxicillin Generic | 51 | 87 | 19 | $658 |
| Cefadroxil Generic | 51 | 91 | 14 | $15K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 47 | 67 | 13 | $480 |
| Cefazolin Sodium Generic | 45 | 45 | 16 | $2,031 |
| Meropenem Generic | 30 | 30 | Under 11 | $9,214 |
| Cefepime Hcl Generic | 24 | 24 | Under 11 | $5,014 |
| Vemlidy Tenofovir Alafenamide | 23 | 23 | Under 11 | $36K |
Brand drugs: 272 claims; generic drugs: 1,263 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Laila E Woc-Colburn $291 ($291 in general payments such as food, travel and fees) from 1 company. The largest payer was Ortho-Clinical Diagnostics, Inc. with $291.
| Company | Payments | Amount |
|---|---|---|
| Ortho-Clinical Diagnostics, Inc. | 2 | $291 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.